التفاصيل البيبلوغرافية
| العنوان: |
Provider delay in treatment initiation and its influence on survival outcomes in women with operable breast cancer |
| المؤلفون: |
Flores-Balcázar, Christian H., Flores-Luna, Ma. L., Villarreal-Garza, Cynthia M., Bargalló-Rocha, Juan E. |
| المصدر: |
Reports of Practical Oncology and Radiotherapy; Vol 25, No 2 (2020); 271-275 |
| بيانات النشر: |
Via Medica |
| سنة النشر: |
2020 |
| المجموعة: |
Via Medica Journals |
| مصطلحات موضوعية: |
BrCa, CSS, ER, HR, IQR, OR, Timing of cancer treatment, Treatment delay, Breast cancer chemotherapy, Breast cancer surgery, Breast cancer radiotherapy |
| الوصف: |
AimThe goal of this study was to determine whether a delay in starting treatment via surgery or neoadjuvant chemotherapy is related to a decrease in cancer-specific survival (CSS) in women with operable breast cancer (BrCr).BackgroundLimited medical infrastructure and a lack of cancer prevention awareness in low- and middle-income countries have caused high BrCr incidence and mortality rates.MethodsWe analyzed a retrospective cohort of 720 women treated at a single center from 2005 to 2012. CSS estimates were obtained by the Kaplan-Meier method. A Cox model of proportional risks was performed to obtain the risk of dying from BrCr. We also obtained the risk according to the category of treatment initiation.ResultsWomen with locally advanced stages and without hormone receptor expression were more likely to initiate treatment after 45 days. Patients in Stage IIIA had a 78.1% survival if treatment was initiated before 45 days (95% CI, 0.70–0.84) and 63.6% survival if treatment was started after 45 days (95% CI, 0.44–0.78; p |
| نوع الوثيقة: |
other/unknown material |
| وصف الملف: |
application/pdf |
| اللغة: |
English |
| العلاقة: |
https://journals.viamedica.pl/reports_of_pract_oncol_radiother/article/view/74071Test |
| DOI: |
10.1016/j.rpor.2020.02.002 |
| الإتاحة: |
https://doi.org/10.1016/j.rpor.2020.02.002Test
https://journals.viamedica.pl/reports_of_pract_oncol_radiother/article/view/74071Test |
| حقوق: |
Completion of the online submission form electronically (the Author's Statement) is tantamount to automatic transfer of the copyright for publishing and distribution of the submitted material (in all current and future forms and fields of exploitation) to the Copyright Owner, i.e. Greater Poland Cancer Centre (Poznan, Poland), on condition that these materials are accepted for publication. The authors agree not to publish any data or figures presented in their work in any place or in any language without the prior written consent of the Publisher. |
| رقم الانضمام: |
edsbas.AD83232C |
| قاعدة البيانات: |
BASE |
